Cancer

Cantargia Reports US Regulatory Approval to Start Pancreatic Cancer Phase IIb Trial with Nadunolimab

LUND, SWEDEN / ACCESSWIRE / February 20, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported that after…

9 months ago

Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company

CHICAGO, IL / ACCESSWIRE / February 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

9 months ago

Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC

Company Also Ranked in Top 5 of Pharmaceuticals and Biotech IndustryFOSTER CITY, CA / ACCESSWIRE / February 20, 2024 /…

9 months ago

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm

Houston, Texas--(Newsfile Corp. - February 20, 2024) - Cannabis Bioscience International Holdings, a Houston-based company trading on the OTC Markets…

9 months ago

Florence Healthcare and Slope Unite Forces to Address Site Technology Ecosystem Demand

Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All…

9 months ago

Yunu Emerges as Industry Leader to Address the Way Imaging Data Impacts Breakthrough Therapy Development

Fast-growing innovator brings first-of-its-kind imaging ecosystem to clinical trialsCARY, NC / ACCESSWIRE / February 20, 2024 / With the rapid…

9 months ago

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…

9 months ago

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing…

9 months ago

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

Board expertise encompasses oligonucleotide research, development, manufacturing and commercialization to support development of ECO Synthesis™ manufacturing platform Masad Damha, PhD…

9 months ago